MMU Research and Knowledge Exchange Blog

Funding opportunities, news and guidance from RKE at Manchester Met


Leave a comment

Kidney Research Grants Open for Applications

The Kidney Research UK Project Grants and Innovation Grants will be opening this month for applications.

Project Grant

These are stand-alone research project that will advance our knowledge of kidney disease and refine current treatments or lead to new advances

Funding available: up to £200,000

Funding duration: up to 3 years

Deadline: March 2020

Outcome: July 2020

Innovation Grants

These are stand-alone research studies that will advance our knowledge of kidney disease particularly for new hypotheses. Initial pilot/supporting data is required prior to a full research project.

Funding available: up to £40,000

Funding Duration: up to 2 years

Deadline: March 2020

Outcome: July 2020

If you’re interested in applying for either of these opportunities then please visit the Kidney Research UK website for further details.

If you would like to apply for this opportunity then please contact your Research Development Team.


Leave a comment

Breast Cancer Now: Project Grants Now Open

The first round of Breast Cancer Now Project Grants are open for applications. Project grants are aimed at established researchers who have a strong track record in their field, and who want to work in one of the charities priority areas. They are also committed to supporting new investigators in breast cancer research and encourage applications from talented researchers at the start of their independent career.

Award Amount: Up to £230,000

Duration: One to Three years

Deadline: Tuesday 3rd March 2020

The aim of project grants is to support scientific excellence and innovative research into breast cancer including improvements in; prevention, detection and treatment of all forms of breast cancer, welcoming applications from all disciplines.

It is expected that the awards will enrich scientific understanding and expertise in breast cancer research with the grants committee assessing applications based on the research plan, clear relevance to breast cancer research and the perceived outcomes that will lead to significant advance in understanding breast cancer and it’s impact.

For further information about the scheme please visit the Breast Cancer Now website.

If you would like to apply for this scheme then please contact your Research Development Team.


Leave a comment

Pre-announcement: MRC Launching New Board to Support Applied Global Health Research

MRC will be launching a new Research Funding Board in January 2020 and will be inviting applications in applied global health research,

The new Board will fund global health research that is embedded within local contexts in low- and middle-income countried (LMICs) where proposals should focus on real world, practical applications to improve health.

The research objectives will focus on health impact, but inputs and activities need not be limited to the health sector and proposals will be encouraged to be multidisciplinary. The Boards remit will have a broad focus including the MRC’s existing health priority areas such as environment and health, urban health, maternal and neonatal health, adolescent health, early childhood development, multimorbidity, and implementation research.

Applications led by UK PI’s must include LMIC co-applications and be founded upon genuine equitable partnerships.

Key Dates

The Board will have two funding rounds per year. Dates for the first two rounds are as follows:

Round 1

Outline Deadline: 7th April 2020

Outcome of outline: July 2020

Full Stage Deadline: 6th October 2020

Final Outcome: February 2021

Round 2

Outline Deadline: 6th October 2020

Outcome of outline: February 2021

Full Stage Deadline: April 2021

Final Outcome: July 2021

For further information please visit the MRC website.


Leave a comment

Pre-call announcement: UK-Japan Regenerative Medicine and Stem Cell Research Initiative

The MRC and the Japan Agency for Medical Research and Development (AMED) are pleased to announce they will soon be launching a joint call for research proposals focused on Regenerative Medicine and Stem Cell Research.

This initiative will support collaborative (UK-Japanese) research projects that build upon fundamental insights and initial early-stage discoveries, to advance regenerative approaches towards clinical use in the future and to utilise stem cells as medial research tools.

Applications will be particularly welcome for projects focusing on:

  • Human cell engineering, gene editing and cellular reprogramming approaches where a clear future therapeutic goal has been identified.
  • Investigations into modulation of the human tissue niche, or improving understanding of the niche; this may include for example establishing mechanisms for differentiation in transplanted stem cells or understanding immunological barriers.
  • Improving efficacy of engraftment and regeneration of transplanted cells.
  • Developing tools, technologies and methods to enable translational regenerative medicine research including, but not limited to, in-vivo cell imagining approaches or high throughput screening techniques.
  • Creating novel on-vitro models utilising stem cells which could be used for robust predictive safety testing or as drug screening models.

Alternative project outcomes such as therapeutic candidates, medical devices and diagnostic agents mat also be supported by this call.

MRC will make up to £5m available to support the UK component of the collaborative research projects. It is expected that the available funds will support approximately 8 projects/

For further details and updates please visit the MRC and AMED websites in December.


Leave a comment

Myotubular Trust – Call for Projects

The Myotubular Trust is a registered charity that was set up to find a cure and treatments for any genetic form of centronuclear and myotubular myopathy.

The trust has launched a call for projects that will help to find a cure or treatment of any form of centronuclear and myotubular myopathy. They will be focusing on research that would generally not be funded by public or industrial funding sources.

Duration: 2 – 3 years (Project Grant), 3-4 years (Fellowship)

Deadline: Friday 15th March – 5pm

Applications are particularly encouraged investigating new technologies to research into centronuclear and myotubular myopathy; interventional trials; and those which may involve collaboration between different medical disciplines and/or different research institutions.

For further information please visit the Myotubular Trust Website.

If you would like to apply for this scheme please contact your research development team.


Leave a comment

Latest Opportunities from NIHR

Funding

Health Technology Assessment Programme (HTA):

19/07 Anti-TB Drug Hepatotoxicity and Treatment Reintroduction

Programme Development Grants

Competition 24

Programme Grants for Applied Research

Competition 29

Public Health Research Programme

19/01 Improving Health and Wellbeing for People who are at Risk of or Exposed to Adverse Childhood Experiences (ACEs)

19/02 Interventions that Reduce Harmful Substance Use With a Focus on Novel Psychoactive Substances

19/03 Systems Approaches to Local Influences on Food Choices and Diet

19/04 Community Focused Approaches That Mobilise People as Assets

Joint NIHR and Medical Research Council Opportunity

Global Maternal and Neonatal Health 2019 – Outlines.


Leave a comment

Research & Innovation in the NHS Long Term Plan

Last week the NHS released their long term plan with funding of £20.5 billion backing the new plans up to 2023, of course research and innovation features within the plan which is summarised below.


Research and innovation are key to both the NHS and UK economy. ‘Research-active’ hospitals have lower mortality rates with patients benefiting from earlier diagnosis, more effective treatments and faster recovery. The government plans to treble it’s industry contract and R&D collaborative research with the NHS over the next ten years to nearly £1 billion.

The NHS will be working to increase the number of people registered to participate in health research to 1 million by 2023/24, one way of doing this will be by allowing people to register their interest via an app by 2020.

There is a particular focus on investing in genomics research with the aim to be the first national health care system to offer whole genome sequencing as part of routine care. During 2019 seriously ill children who are likely to have rare genetic disorders, children with cancer, and adults suffering from certain rare conditions or specific cancers, will begin to be offered whole genome sequencing.

Uptake of proven, affordable innovations will be accelerated through a new Medtech funding mandate. This applies to health tech products (other than pharmaceuticals) assessed as cost saving by NICE. The number of NICE evaluations will also be significantly increased giving greater scope for assessment of digital products in particular.


For more information about the NHS long term plan you can visit the plans here.